HFM1
Basic information
Region (hg38): 1:91260766-91404856
Previous symbols: [ "SEC63D1" ]
Links
Phenotypes
GenCC
Source:
- male infertility with azoospermia or oligozoospermia due to single gene mutation (Disputed Evidence), mode of inheritance: AR
- premature ovarian failure 9 (Limited), mode of inheritance: Unknown
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Premature ovarian failure 9 | AR | Obstetric | Genetic knowledge may be beneficial to allow interventions such as preserving eggs in women with premature ovarian insufficiency | Endocrine; Obstetric | 24597873 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the HFM1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 6 | |||||
missense | 60 | 70 | ||||
nonsense | 0 | |||||
start loss | 1 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 4 | 1 | 5 | |||
non coding | 2 | |||||
Total | 0 | 2 | 61 | 12 | 5 |
Variants in HFM1
This is a list of pathogenic ClinVar variants found in the HFM1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-91261298-T-C | not specified | Uncertain significance (Jul 31, 2024) | ||
1-91261300-C-T | not specified | Uncertain significance (Dec 05, 2024) | ||
1-91261338-T-G | not specified | Uncertain significance (May 23, 2024) | ||
1-91262277-A-T | not specified | Uncertain significance (Sep 12, 2023) | ||
1-91262279-A-T | not specified | Uncertain significance (May 02, 2024) | ||
1-91262316-T-C | not specified | Uncertain significance (Dec 03, 2021) | ||
1-91262352-TC-T | - | no classification for the single variant (-) | ||
1-91262365-T-G | not specified | Uncertain significance (Oct 26, 2022) | ||
1-91262366-T-G | not specified | Uncertain significance (Nov 22, 2021) | ||
1-91262505-AG-A | Premature ovarian failure 9 | Uncertain significance (-) | ||
1-91262569-G-A | not specified | Uncertain significance (Sep 26, 2023) | ||
1-91266061-GG-C | Premature ovarian failure 9 | Pathogenic (Mar 06, 2014) | ||
1-91266111-T-A | not specified | Likely benign (Jan 23, 2018) | ||
1-91267768-T-A | not specified | Uncertain significance (May 07, 2024) | ||
1-91267806-A-T | not specified | Uncertain significance (Sep 27, 2022) | ||
1-91267816-C-A | not specified | Uncertain significance (Jan 11, 2023) | ||
1-91267840-T-G | not specified | Uncertain significance (Jan 07, 2022) | ||
1-91273797-T-C | not specified | Uncertain significance (Jan 06, 2023) | ||
1-91274758-G-C | not specified | Uncertain significance (Nov 06, 2023) | ||
1-91274768-A-C | not specified | Uncertain significance (Feb 03, 2022) | ||
1-91274787-C-T | not specified | Uncertain significance (Sep 22, 2023) | ||
1-91276627-C-T | Azoospermia | Pathogenic (Dec 20, 2021) | ||
1-91276683-G-C | not specified | Uncertain significance (Sep 22, 2023) | ||
1-91276689-T-C | not specified | Uncertain significance (Apr 09, 2024) | ||
1-91276702-T-C | not specified | Uncertain significance (Jun 17, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
HFM1 | protein_coding | protein_coding | ENST00000370425 | 38 | 144104 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
4.73e-32 | 0.0809 | 125603 | 0 | 137 | 125740 | 0.000545 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.742 | 627 | 682 | 0.920 | 0.0000319 | 9464 |
Missense in Polyphen | 142 | 181.84 | 0.78089 | 2547 | ||
Synonymous | 0.593 | 215 | 226 | 0.950 | 0.0000105 | 2551 |
Loss of Function | 2.07 | 60 | 80.0 | 0.750 | 0.00000415 | 1083 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000768 | 0.000755 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000638 | 0.000598 |
Finnish | 0.000696 | 0.000693 |
European (Non-Finnish) | 0.000730 | 0.000704 |
Middle Eastern | 0.000638 | 0.000598 |
South Asian | 0.000407 | 0.000392 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Required for crossover formation and complete synapsis of homologous chromosomes during meiosis. {ECO:0000250|UniProtKB:D3Z4R1}.;
Intolerance Scores
- loftool
- 0.986
- rvis_EVS
- -0.72
- rvis_percentile_EVS
- 14.27
Haploinsufficiency Scores
- pHI
- 0.0728
- hipred
- N
- hipred_score
- 0.307
- ghis
- 0.490
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.177
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Hfm1
- Phenotype
- endocrine/exocrine gland phenotype; reproductive system phenotype;
Gene ontology
- Biological process
- resolution of meiotic recombination intermediates
- Cellular component
- Molecular function
- nucleic acid binding;helicase activity;ATP binding